Background {#Sec1}
==========

Fast Track protocols, also known as Enhanced Recovery After Surgery (ERAS®), or Enhanced Recovery Programmes (ERPs), have been developed by surgeons and anaesthesiologists to reduce the surgical stress response, accelerate recovery, and improve overall post-operative outcomes \[[@CR1]\]. They were initially introduced in the early nineties by Kehlet and colleagues as standard of care for colorectal surgery, and have spread to other surgical specialties \[[@CR1], [@CR2]\]. ERPs generally include about 20 evidence-based intervention components during the peri-operative period, and require the active participation of a multidisciplinary team and the patient \[[@CR3]--[@CR5]\].

Due to demographic aging and advances in surgical and anaesthetic techniques, the demand for surgical procedures in older persons is rapidly increasing \[[@CR6], [@CR7]\], but the ability of older patients to actively participate in ERPs and to achieve the same results as younger patients has been debated \[[@CR8], [@CR9]\]. After all, ERPs were not specifically designed for older patients. On the other hand, older patients might actually benefit more than younger patients, because they are more susceptible to adverse post-operative outcomes and longer hospital stays \[[@CR9], [@CR10]\].

In 2014, Bagnall et al. published a first review about the safety, feasibility and efficacy of ERPs in patients aged 65 and over undergoing colorectal surgery, including 16 studies published before February 2014 \[[@CR11]\]. Launay-Savary et al. performed a new search until 2015 and included two extra studies: a meeting abstract and a study later retracted from literature \[[@CR12]\]. With new literature emerging since the latest reviews, and ERPs being further standardised, a new systematic literature review was deemed useful.

The primary objective of this review was to map intervention components of ERPs in patients aged 65 years and older undergoing elective colorectal surgery. In addition, we analysed adherence to individual ERP components and outcomes of the ERPs in patients aged 65 years and older.

Methods {#Sec2}
=======

This review was performed in the framework of the PRISMA guidelines ([www.prisma-statement.org](http://www.prisma-statement.org)) and was registered in PROSPERO, the international prospective register of systematic reviews (registration number CRD42018084756).

Search strategy {#Sec3}
---------------

An electronic bibliographic database search through PUBMED, EMBASE, and CINAHL was performed.

The following search string was used for PubMed and adapted for the other databases (Additional file [1](#MOESM1){ref-type="media"}): ((("colorectal surgery"\[mesh\]) OR ((colorectal\[tiab\] OR colon\[tiab\] OR colonic\[tiab\] OR colectomy\[tiab\] OR rectum\[tiab\] OR rectal\[tiab\] OR pelvic\[tiab\]) AND (surgery\[tiab\] OR surgical\[tiab\] OR operation\[tiab\] OR operative\[tiab\] OR resection\[tiab\]))) AND (ERAS\[tiab\] OR "enhanced recovery" \[tiab\] OR "accelerated recovery" \[tiab\] OR "expedited recovery" \[tiab\] OR "fast track" \[tiab\] OR multimodal\[tiab\] OR multi-modal\[tiab\])). The search was limited to English, Dutch, French, German and Spanish articles published between January 1, 2000 and November 17, 2017. Reference lists and PubMed-citations of the included articles, as well as former systematic review articles related to the topic, were cross-referenced to retrieve additional relevant studies.

Selection of relevant papers {#Sec4}
----------------------------

All studies including adults aged 65 and over, undergoing elective colorectal surgery, were eligible for inclusion. The individual components of the applied ERP had to be described in detail, including at least one of the following outcomes for the (subgroup of) older patients: length of stay (LOS) or post-operative morbidity. Study designs included were randomised and non-randomised controlled trials, before-after studies and prospective and retrospective observational studies. Studies were excluded if they included patients undergoing emergency surgery, if they referred to general guidelines instead of giving a detailed description of their ERP protocol, if they focused on limited (\< 5) intervention components, or if no full text was available. Two reviewers (KF, MP) independently screened the titles and abstracts of the articles retrieved by the search and removed duplicate articles, using Endnote. Full texts of relevant abstracts and articles obtained by cross-referencing were assessed for inclusion (KF, MM). Any discrepancies were discussed with a fourth reviewer (MD).

Data extraction and synthesis {#Sec5}
-----------------------------

Two reviewers (MP, MM) extracted data, each from half of the included studies, using standardised data extraction forms. A third reviewer (KF) double-checked the correctness and completeness of the extracted data. In case of disagreement, a fourth reviewer (MD) was consulted. The following characteristics of the included studies were extracted: first author, year of publication, country and setting, study design, study population, in- and exclusion criteria, sample and age distribution, and the subsample of older people in an ERP included in this review. The reported ERP intervention components were grouped into 20 key components, in line with the 2012 ERAS® Society guidelines for peri-operative care in elective colonic and rectal/pelvic surgery \[[@CR3], [@CR4]\]. The total number of studies including a certain ERP intervention component as well as the total number of ERP intervention components per study were calculated. Apart from LOS and post-operative morbidity, the following outcomes, if available, were reported: post-operative mortality, time to reach discharge criteria, adherence to ERP components, 30-day readmission rate and reoperation rate. Post-operative morbidity and mortality were considered in-hospital and within 30 days of surgery. Post-operative morbidity was reported as the percentage of patients experiencing post-operative complications (severity grades I to IV according to the Clavien-Dindo classification) \[[@CR13]\]. If the study reported the percentage of older patients in which an intended ERP component was actually applied, this percentage was considered as the adherence to that ERP component. The most frequently reported discharge criteria, also referred to as ERP recovery goals, were summarised by reporting the time (in days or hours) to reach each recovery goal (i.e. no morbidity evidence, ambulation, first flatus, first stool, oral intake, pain control with oral drugs) \[[@CR1], [@CR14]\].

Risk of bias (quality) assessment {#Sec6}
---------------------------------

The methodological quality of the included studies was assessed independently by three reviewers (KF, MP and MM) through the Methodological Index for Non-Randomised Studies (MINORS), containing eight items (the maximum item score per item is 2, the ideal global score 16) \[[@CR15]\]. Any discrepancies were discussed and agreed upon with a fourth reviewer (MD).

Data synthesis and analysis {#Sec7}
---------------------------

Results from individual studies and study groups are provided in the tables as percentages and averages (means or medians). To summarize the data in the manuscript, medians and ranges across study groups were calculated. Due to many differences among studies regarding study population, age groups, ERPs, risk of bias, definitions of outcomes and other methodological aspects, a formal meta-analysis was not performed.

Results {#Sec8}
=======

Article selection {#Sec9}
-----------------

The search generated 4562 articles (Fig. [1](#Fig1){ref-type="fig"}). After removing 1429 duplicates and excluding 2810 articles based on title and abstract, 323 full texts plus 2 additional articles found by cross-referencing, were evaluated for inclusion. Finally, 21 articles were included \[[@CR16]--[@CR36]\]. Five of the included articles did not provide ERP details, but were included because the applied ERP was described in detail in another publication \[[@CR18], [@CR21], [@CR22], [@CR25], [@CR26], [@CR33]\]. Although inclusion periods of the two studies published by Braga et al. partially overlapped, we reported the results as two individual studies \[[@CR19], [@CR20]\].Fig. 1PRISMA flowchart showing the study selection process

Study and patient characteristics {#Sec10}
---------------------------------

Three studies compared ERPs with conventional care in an older age group \[[@CR16], [@CR24], [@CR28]\] (Table [1](#Tab1){ref-type="table"}). Ten studies compared ERPs in old versus young patient groups \[[@CR17], [@CR18], [@CR20], [@CR22], [@CR23], [@CR25], [@CR27], [@CR29], [@CR31], [@CR35]\], while 2 studies compared ERPs in different older age groups \[[@CR19], [@CR32]\]. Three studies described ERPs in a single older age group \[[@CR21], [@CR34], [@CR36]\]. Three studies investigated patient factors that influence ERP outcomes, including age \[[@CR26], [@CR30], [@CR33]\]. A total of 7610 patients were included in all studies, of whom 3495 (46%) patients (those ≥65 years in whom an ERP was applied) were considered in this review. Four studies divided the older patients in different age groups \[[@CR17]--[@CR19], [@CR32]\]. As a consequence, the 21 studies included in this review comprised 26 study groups.Table 1Study and patient characteristics (original studies included in this review)Original studyCountry and settingStudy-designPopulationSampleAge median (range) or mean (±SD), in yInclusion criteria\
(original study)Exclusion criteria\
(original study)Zeng 2017 \[[@CR16]\]ChinaMonocentric, academicDatabase analysisColorectalLaparoscopicCancer**94 ERP ≥ 75y**157 CC ≥75y**78 (75--88)**78 (75--90)≥75yLaparoscopic colorectal surgeryColorectal cancerEmergency surgeryNon-radical resectionTNM stage IVMulti-organ resectionPirrera 2017 \[[@CR17]\]ItalyMonocentric, non-academicDatabase analysisColorectalLaparoscopicCancer/Benign**203 ERP \> 75y175 ERP 66-75y**211 ERP ≤65y**80 (range NR)69 (range NR)**56 (range NR)Colorectal resectionScheduled for laparoscopic approachEmergency surgeryPalliative procedureForsmo 2017 \[[@CR18]\]NorwayMonocentric, academicSecondary analysis of RCT dataColorectalOpen/LapCancer/Benign**19 ERP ≥ 80y56 ERP 66-79y**79 ERP ≤ 65y**83 (80--89)72 (66--78)**58 (23--65)≥18yColorectal surgeryWith or without stomaMalignant or benignMulti-organ resectionASA 4Emergency surgeryImpaired mental capacityBraga 2017 \[[@CR19]\]Peri-operative Italian Society Registry(11 hospitals)Database analysisColorectalOpen/LapCancer/Benign**93 ERP \> 80 y117 ERP 76-80y105 ERP 71-75y84 (SD ± 3)77 (SD ± 2)73 (SD ± 1)**\>70yElective colorectal surgery/Braga 2016 \[[@CR20]\]Peri-operative Italian Society Registry(11 hospitals)Database analysisColorectalOpen/LapCancer/Benign**167 ERP ≥ 70y, ASA 1--2162 ERP ≥ 70y, ASA 3--4**279 ERP \<70y, ASA 1--298 ERP \<70y, ASA 3--4**77 (SD ± 4.6)78 (SD ± 5.3)**58 (SD ±9)63 (SD ±5.7)Elective colorectal surgery/Gonzalez-Ayora 2016 \[[@CR21]\]SpainMulticentric, academicDatabase analysisColorectalOpen/LapCancer/Benign**188 ERP ≥ 70y79 (70--93)**≥70yColorectal surgeryEmergency surgeryPalliative procedurePedziwiatr 2015 \[[@CR22]\]PolandMonocentric, academicDatabase analysisColorectalLaparoscopicCancer**34 ERP ≥ 80y**43 ERP ≤55y**83 (IQR 82--87)**50 (IQR 44--54)≥80y or ≤ 55yLaparoscopic colorectal surgeryColorectal adenocarcinomaEmergency surgeryMulti-organ or transanal resectionConcomitant IBDICU stay after surgeryKisialeuski 2015 \[[@CR23]\]PolandMonocentric, academicProspective observational cohort studyColorectalLaparoscopicCancer**49 ERP \> 65y**43 ERP ≤65y**76.3 (SD NR)**55.8 (SD NR)Laparoscopic colorectal surgery Colorectal cancerEmergency surgeryMulti-organ resectionJia 2014 \[[@CR24]\]ChinaMonocentric, academicRCTColorectalOpenCancer**117 ERP ≥ 70y**116 CC ≥70y**75.7 (SD ± 4.2)**74.8 (SD ±4.0)≥70yAdmitted for open curative resectionColorectal carcinomaDementia, Parkinson, alcohol intake ≥250 g/d, long term sleeping pills or anxiolytics, anaesthesia ≤30dIntra-operative blood transfusion or ICU stay after surgeryKeller2013 \[[@CR25]\]USAMonocentric, academicDatabase analysisColonicLaparoscopicCancer/Benign**153 ERP ≥ 70y**302 ERP \<70y**77.9 (SD ± 6.1)**52.4 (SD ±13.7)Elective laparoscopic colon resection (conversions included)Incomplete medical or financial recordsFeroci 2013 \[[@CR26]\]ItalyMonocentric, non-academicDatabase analysisColorectalOpen/LapCancer/Benign**204 ERP ≥ 75y**402 ERP \<75yOverall:70 (30--94)Elective colorectal resection (multiple previous laparotomies are included)ASA grades 1 to 4Medically unfit for surgeryCancer with distant metastasis\<18y or pregnantBaek 2013 \[[@CR27]\]KoreaMonocentric, academicProspective observational cohort studyColorectalLaparoscopicCancer**77 ERP ≥ 70y**226 ERP \<70y**74.8 (SD ± 4.2)**56.7 (SD ±8.9)Laparoscopic or robotic surgery Colorectal cancerEmergency surgeryASA 4ICU stay after surgeryConversion (laparoscopic to open)Wang 2012 \[[@CR28]\]ChinaMonocentric, academicRCTColorectalLaparoscopicCancer**40 ERP ≥ 65y**38 CC ≥65y**71 (65--81)**72 (65--82)≥ 65yLaparoscopic colorectal resectionColorectal cancerDistant metastasis (involving pelvic, urethra of iliac vessel invasion)Poor cardiopulmonary functionPawa 2012 \[[@CR29]\]UKMonocentric, academicDatabase analysisColorectalOpen/LapCancer/Benign**130 ERP ≥ 80y**558 ERP \< 80y**83 (80--95)**66 (17--79)Colorectal resectionNoneWalter 2011 \[[@CR30]\]UKMonocentric, non-academicDatabase analysis; retrospective control groupColorectalOpen/LapCancer/Benign**68 ERP ≥ 80y**332 ERP \< 80y200 CCOverall:67 (IQR 56--77)69 (IQR 57--78)Major colorectal resectionsFirst 400 consecutive, non-selected, patients managed within an ERPLast 200 patients pre-ERPEmergency surgeryKahokehr 2011 \[[@CR31]\]New ZealandMonocentric, academicProspective observational cohort studyColonicOpen/LapCancer/Benign**22 ERP \> 75y**78 ERP ≤75yOverall:67.5 (IQR 31--92)Elective colonic surgery within an ERPRectal cancer ≤15 cm from the anal verge, patients requiring a stoma or unable to participate (language, cognitive impairment, ASA ≥4)Rumstadt 2009 \[[@CR32]\]GermanyFTCII programme(24 hospitals)Database analysisColonicOpen/LapCancer/Benign**207 ERP ≥ 80y535 ERP 70-79y74.7 (70--79.9)83.4 (80--95.7)**≥ 70yElective colonic resectionEmergency surgeryPerforation or abscess with septic inflammatory response syndromeHendry 2009 \[[@CR33]\]UK, Norway, Sweden, The NetherlandsMulticentric, academicDatabase analysisColorectalOpenCancer/Benign**194 ERP ≥ 80y**839 ERP \<80Overall:59 (IQR 69--78)Elective open colorectal surgery with formation of an anastomosisIn case of rectal cancer: tumour in the upper 1/3 of the rectum and allows anastomosis in the middle 1/3ASA grade 1 to 4Total mesorectal excisionScharfen-berg 2007 \[[@CR34]\]GermanyMonocentric, academicProspective observational cohort studyColonicOpen/LapCancer/Benign**74 ERP \> 70y74 (71--88)**\>  70yElective colonic resectionBenign or malignant diseaseNot operated on electivelySenagore 2003 \[[@CR35]\]USAMonocentric, academicRetrospective observational cohort studyColonicOpen/LapCancer/Benign**50 ERP ≥ 70y, lap123 ERP ≥ 70y, open**181 ERP \<60y, lap122 ERP \<60y, open**77.5 (SE ± 4.6)77.8 (SE ± 5.4)**42.4 (SE ±12.3)46.7 (SE ±9.8)4 age-matched cohortsElective segmental colectomyLaparoscopic/open when excluded for laparoscopic approach based on standardised criteriaPrior major abdominal surgeryIncomplete dataBardram 2000 \[[@CR36]\]DenmarkMonocentric, academicRetrospective observational cohort studyColonicLaparoscopicCancer/Benign**39 ERP ≥ 70y, lap**11 ERP ≥70y, convertedOverall:81 (70--93)Laparoscopic colonic resectionLaparoscopic surgery70--75y: benign disease or malignant disease with severe cardiopulmonary disease\>  75y: malignant diseaseNot electiveTumours in the transverse colon or rectumPatients not self-caring and not admitted directly from homeLEGEND: *RCT* randomised controlled trial, *ERP* enhanced recovery programme, *CC* conventional care, *vs* versus, *y* years old, *g* gram, *d* day, *lap* laparoscopic, *SD* standard deviation, *SE* standard error of the mean, *NR* not reported, *TNM* tumour node metastasis, *ASA* American society of anaesthesiologists physical status class, *IBD* inflammatory bowel disease, *ICU* intensive care unit, *FTCII* fast track colon II open quality assurance programme; Bold: patient group included in this review

Risk of bias (quality) assessment {#Sec11}
---------------------------------

The scores on the MINORS quality and risk of bias assessment ranged from 8 to 14 out of 16 (Additional file [2](#MOESM2){ref-type="media"}). Only 8 studies had a clearly stated aim, including the population, the intervention and at least one primary outcome. Although not always divided into primary and secondary endpoints, all studies had endpoints appropriate to the aim of the study. Lower total scores were due to non-consecutive inclusion of patients, non-prospective collection of data, absence of prospective study size calculation, or unblinded assessment of the study endpoints.

Components of the ERP {#Sec12}
---------------------

The number of ERP intervention components in the described ERP protocols varied between 7 and 16, with a median of 13 (Table [2](#Tab2){ref-type="table"}). All programmes described early post-operative mobilisation, early post-operative oral intake, opioid sparing multimodal post-operative analgesia, early urinary catheter removal, and avoidance of nasogastric tubes as part of the intervention. Prevention of post-operative ileus (by chewing gum, laxatives, or Alvimopan), post-operative nausea and vomiting (PONV) prophylaxis or treatment, avoidance of sedative premedication, and pre-operative optimisation were not mentioned in over half of the studies. None of the ERPs mentioned peri-operative glycaemic control. Anaesthetic protocol information was often very limited. Therefore the scoring for 'standard anaesthesia protocol' was based on the described regional anaesthesia technique, taking into account an evolution in the recommendations over time: In the past epidural anaesthesia was recommended in all patients. In the 2012 ERAS® Society guidelines epidural anaesthesia remains the standard in open surgery, but for laparoscopic surgery spinal analgesia or PCIA are recommended as an alternative \[[@CR3], [@CR4]\].Table 2Reported intervention components of the ERP20 Components (defined according to ERAS® Society guidelines 2012 \[[@CR3], [@CR4]\])Zeng 2017 \[[@CR16]\]Pirrera 2017 \[[@CR17]\]Forsmo 2017 \[[@CR18]\]Braga 2017 \[[@CR19]\]Braga 2016 \[[@CR20]\]Gonzalez-Ayora 2016 \[[@CR21]\]Pedziwiatr 2015 \[[@CR22]\]Kisialeuski 2015 \[[@CR23]\]Jia 2014 \[[@CR24]\]Keller 2013 \[[@CR25]\]Feroci 2013 \[[@CR26]\]Baek 2013 \[[@CR27]\]Wang 2012 \[[@CR28]\]Pawa 2012 \[[@CR29]\]Walter 2011 \[[@CR30]\]Kahokehr 2011 \[[@CR31]\]Rumstadt 2009 \[[@CR32]\]Hendry 2009 \[[@CR33]\]Scharfenberg 2007 \[[@CR34]\]Senagore 2003 \[[@CR35]\]Bardram 2000 \[[@CR36]\]**Total per ERP component (median = 13.5)**1. Pre-operative counselling011111110111011111111**18**2. Pre-operative optimisation000001010010010000000**4**3. Avoidance of bowel preparation in colonic surgery110111110011001110000**12**4a. Limited pre-operative fasting time111000001011001101000**16**4b. Carbohydrate loading0111111110001111010005. Avoid sedative premedication001110000010000001000**5**6. Prophylaxis against thromboembolism011111110111010000000**11**7. Antimicrobial prophylaxis011111110111010000101**13**8. Standard anaesthetic protocol^1^101110101110101111101**15**9. PONV prophylaxis/treatment000110110010000111000**8**10. Laparoscopy and modifications of surgical acces^2^111000110101111011011**14**11. Avoidance of nasogastric tubes111111111111111111111**21**12. Prevention intra-operative hypothermia011111000011011101000**11**13. Peri-operative fluid management111111110001111111101**17**14. Avoid abdominal or pelvic drains111111111000011110000**13**15. Early removal of urinary catheters111111111111111111111**21**16. Prevention of post-operative ileus^3^011000010000100011100**7**17. Opioid sparing multimodal post-operative analgesia111111111111111111111**21**18. Early oral intake111111111111111111111**21**19. Peri-operative glycaemic control000000000000000000000**0**20. Early mobilisation111111111111111111111**21Total ERP components per article (median = 13)1115161616141516810151310141313131410710**LEGEND: 0 = not reported as a component of the ERP; 1 = reported as a component of the ERP; ERP: enhanced recovery programme; PONV: post-operative nausea and vomiting; ^1^based on the regional anaesthesia technique (0: no/inadequate information, epidural anaesthesia as a routine procedure for laparoscopic surgery in studies that started including after 2012; 1: epidural anaesthesia for all patients, except for patients undergoing laparoscopic surgery after 2012); ^2^automatically score 1 if only laparoscopic patients were included in the study; ^3^chewing gum or laxatives or Alvimopan

Adherence to the ERP {#Sec13}
--------------------

Nine studies reported adherence rates to a minimum of 1 and a maximum of 15 ERP components \[[@CR19]--[@CR23], [@CR26], [@CR29], [@CR32], [@CR34]\] (Table [3](#Tab3){ref-type="table"}). Adherence was the highest for pre- and intra-operative ERP components, and lower for post-operative components. ERP components with adherence rates ≥80% were: pre-admission counselling, no bowel preparation, limited pre-operative fasting, antithrombotic and antimicrobial prophylaxis, no nasogastric tube, active warming, and limited intra-operative fluids. Other ERP components with adherence rates ≥60% included carbohydrate loading, PONV prophylaxis, and opioid sparing analgesia. 'Early intake of oral liquids' ranged between 49 and 84% on post-operative day (POD) 0 and 'early intake of solid foods' ranged between 51 and 86% on POD 1. Early mobilisation ranged between 55 and 90% on POD 0. Three studies reported 'global compliance' and used the percentage of patients that fully adhered to a number of selected components: global compliance ranged between 56 and 85% \[[@CR20]--[@CR22]\].Table 3Reported adherence to the ERP componentsBraga 2017 \[[@CR19]\]Braga 2016 \[[@CR20]\]Gonzalez-Ayora 2016 \[[@CR21]\]Pedziwiatr 2015 \[[@CR22]\]Kisialeuski 2015 \[[@CR23]\]Feroci 2013 \[[@CR26]\]Pawa 2012 \[[@CR29]\]Rumstadt 2009 \[[@CR32]\]Scharfen-berg 2007 \[[@CR34]\]range71-75y76-80y\> 80y≥ 70y,\
ASA 1,2≥ 70y,\
ASA 3,4≥ 70y≥ 80y\> 65y≥75y≥ 80y70-79y≥80 y\>70y*n* = 105*n* = 117*n* = 93*n* = 167*n* = 162*n* = 188*n* = 34*n* = 49*n* = 204*n* = 130*n* = 535*n* = 207*n* = 741.Pre-admission counselling100999710010010010097--1003.No bowel preparation908690918580100/8083/80--1004a.Limited pre-operative fasting time////////100////4b.Carbohydrate loading808182877310077////73--1005.No sedative premedication4044404040///100////40--1006.Antithrombotic prophylaxis100100100100100100100///1007.Antimicrobial prophylaxis100100100100100100100//1009.PONV prophylaxis7366888861/60/9395/60--9510.Minimal invasive surgery/////////933925/25--9311.No nasogastric tube919390929210010090--10012.Active warming999795100100//100///95--10013.Peri-operative fluid management92/ - Intra-operative fluids (mean ± SD or median and IQR, in ml/kg/h)9.7 (±4.1)8.5 (±4.0)10.3 (±5.9)7.2 (4.8--10.1)8.9 (6.1--12.6)7.2--10.3 - Infusion \< 3000 ml during surgery878181--87 - Stop IV fluid POD 173/24756224--75 - Stop IV fluid POD 2746760706760--7414.No abdominal drain30334437314380//30--8015.Early (per protocol) UC removal70676978626580645656--8017.Multimodal opioid sparing analgesia - Non-opioid based analgesia74928974--92 - Epidural analgesia50515861436255868643--86 - Epidural catheter removal ≤ POD 336384778756936--7818.Early oral intake - Oral liquids POD 0595949565775698449--84 - Oral liquids POD 1909290874646--92 - Oral liquids POD 0--184 - Solid food POD 15357525257827360518651--86 - Solid food POD 2778682923939--9220.Early mobilisation - Out of bed POD 09060715555--90 - Out of bed POD 19391899586945520695320--95Global Compliance66^1^56^1^56^2^85^3^56--85LEGEND: all results in %, unless otherwise specified; PONV: post-operative nausea and vomiting; POD: post-operative day; IV: intravenous; UC: urinary catheter; ml: millilitre; kg: kilogram; h: hour; n: number of patients; y: years old; ASA: American Society of Anaesthesiologists physical status classification; SD: standard deviation; IQR: inter quartile range; ^1^18, ^2^7 and ^3^13 elements used to assess global compliance; /: not applicable (the intervention component was not part of the ERP or (for component 10) the study included laparoscopic patients only)

Outcomes of the ERP {#Sec14}
-------------------

Results from individual studies per study group are given in Table [4](#Tab4){ref-type="table"}. The median post-operative morbidity rate during the hospital stay was 23.5%, ranging from 5 to 37.8% (9 study groups) and was 29.8% at 30 post-operative days, ranging from 18.8 to 52.6% (13 study groups). The in-hospital mortality rate was 0% in 8 study groups, and 1.2 and 1.6% in two others. The median mortality at 30 days was 1.4%, ranging from 0 to 16.2% (17 study groups).Table 4Outcomes of the ERP in older patientsZeng 2017 \[[@CR16]\]Pirrera 2017 \[[@CR17]\]Forsmo 2017 \[[@CR18]\]Braga 2017 \[[@CR19]\]Braga 2016 \[[@CR20]\]Gonzalez-Ayora 2016 \[[@CR21]\]Pedziwiatr 2015 \[[@CR22]\]Kisialeuski 2015 \[[@CR23]\]Jia 2014 \[[@CR24]\]Keller 2013 \[[@CR25]\]Feroci 2013 \[[@CR26]\]Baek 2013 \[[@CR27]\]Wang 2012 \[[@CR28]\]Pawa 2012 \[[@CR29]\]Walter 2011 \[[@CR30]\]Kahokehr 2011 \[[@CR31]\]Rumstadt 2009 \[[@CR32]\]Hendry 2009 \[[@CR33]\]Scharfenberg 2007 \[[@CR34]\]Senagore 2003 \[[@CR35]\]Bardram 2000 \[[@CR36]\]Age (years)≥7566--75\> 7566--79≥8071--7576--80\> 80≥70≥70≥80\> 65≥70≥70≥75≥70≥65≥80≥80\> 7570--79≥80≥80≥70≥70≥70n of patients941752035619105117933291883449117153204774013068225352071947417339MORBIDITY^1^ (in %) - inH21.121.237.823.536.717.026.05.031.2 - 30d24.541.252.621.018.830.129.837.323.038.233.021.620.5MORTALITY (in %) - inH0001.6000001.2 - 30d2.13.65.30000.306.416.2401.11.03.11.45.1LOS (in days)- Post-operative(mean, ±SD)4.7 ± 4.54.7±5.16.2 ± 3.16.7 ± 3.57.3 ± 3.65.4±55.5± 4- Post-operative (median, range)6(4--21)5(2--21)6.5 (3--50)6(IQR 5--8^1^ and 4--7^2^)5 (IQR 3--7)7(3--43)8(4--27)5.5 (IQR 5--6)7 (IQR 6--10)8(2--83)11(1--53)5(3--56)2.5 (2--90) - total(mean, ±SD)9.0±1.755.0±4.91- total(median, range)12(7--31)8 (IQR 5--14)6 (IQR 3--8)READMISSION (in %)- 30d4.64.925.021.15.71.71.12.46.42.96.14.61.511.76.244.72.412.26.45.1REOPERATION (in %)5.31.23.414.310.55545.28.504.11.38.50.67.7LEGEND: ^1^postoperative complications (Clavien-Dindo severity grades I to IV); n: number; d: days; inH: in-hospital; ^1^result for ASA 1,2 patients; ^2^result for ASA 3,4 patients; ASA: American Society of Anaesthesiologists physical status classification; SD: standard deviation; IQR: inter quartile range

LOS was not reported in a uniform way: four studies reported mean post-operative hospital stay (median among the studies 5.5 days, ranging from 4.7 to 7.3 days). Eleven studies reported median post-operative hospital stay (median among the studies 6.0 days, ranging from 2.5 to 11 days). Two studies reported mean total hospital stay (5.0 and 9.0 days, respectively). Three studies reported the median total hospital stay (6.0, 8.0 and 12.0 days, respectively). Two studies reported LOS including readmission days \[[@CR21], [@CR33]\], and one study reported mean LOS for open and laparoscopic surgery separately (9.3 and 4.2 days, respectively) \[[@CR35]\], which explains the absence of LOS-results for these studies in the table.

Among the 16 studies reporting the 30-day readmission rate, the median reported rate was 4.9%, ranging from 1.1 to 25.0% (21 study groups). Among the 12 studies reporting reoperation rate, the median reported rate was 5.0%, ranging from 0.6 to 10.5% (16 study groups). Additional file [3](#MOESM3){ref-type="media"} summarises the attainment of ERP recovery goals. Time to readiness for discharge (TRD or achievement of all recovery goals) was reported in 3 studies with a mean of 6.4, a median of 5.0, and a median of 5.5 days, respectively \[[@CR19], [@CR20], [@CR32]\].

Discussion {#Sec15}
==========

This review analysed intervention components, adherence and outcomes of ERPs in 21 studies in older elective colorectal surgical patients.

The median number of ERP intervention components per study was 13 (range 7--16), compared to 10 (range 4--18) in the earlier review by Bagnall et al. (2014) \[[@CR11]\]. When comparing the studies included in our review, those published before 2014 implemented a median of 13 (range 7--15), and those after 2014 a median of 15.5 (range 11--16) components. This demonstrates that more recent ERPs implement more ERP intervention components than older programmes do. To facilitate comparison of studies, the ERP interventions were grouped into 20 key components based on the 2012 ERAS® Society guidelines \[[@CR3], [@CR4]\]. This explains minor differences in the reported number of ERP components per study between this review and the review by Bagnall et al., as well as minor differences with what authors of the included studies report. Although only 4 studies were conducted after the publication of the 2012 ERAS® Society guidelines, the ERP components in these guidelines do not differ substantially from previous consensus recommendations \[[@CR37], [@CR38]\], nor do they differ from more recent guidelines by other societies (e.g. from the United States, France) \[[@CR39], [@CR40]\]. It is worth mentioning that some components remain somewhat vague in the guidelines: for example, no exact time frame is given for 'early feeding' and 'early mobilisation', nor is the kind of food and the intensity of physical exercise specified. The included studies therefore construct their own protocols, which leads to heterogeneity.

Some ERP components, e.g. pre-operative optimisation, antithrombotic and antimicrobial prophylaxis, PONV prophylaxis and treatment, were less often reported than expected. Possibly, these components are considered peri-operative routine and are therefore not systematically mentioned by the authors in the ERP protocol. Tight peri-operative glycaemic control with insulin was not reported in any of the ERPs. We hypothesize this is due to the fact that it only appeared as an ERP component in the latest[1](#Fn1){ref-type="fn"} guideline in 2012, with a warning for the risk of hypoglycaemia in a ward setting \[[@CR3], [@CR37], [@CR38]\].

To allow for a correct interpretation of the effectiveness of the programmes, adherence to individual ERP components, i.e. which ERP components the patients actually receive (dependent on the providers) and which ones they are able to carry out or tolerate (dependent on the patients), needs to be reported as well \[[@CR18], [@CR41], [@CR42]\]. Nine studies (43%) reported adherence, although the difference between interventions offered and tolerated was often unclear, and adherence was only given for a selection of ERP components. Former studies demonstrated that ERP adherence is lower in the post-operative period compared to the pre- and intra-operative period, and this seems equally true for the older patients in our review \[[@CR43]--[@CR45]\]. This should not automatically be considered as an implementation failure: declining adherence in the post-operative phase might reflect the development of complications, for which additional measures can be taken \[[@CR44]\]. Five studies compared adherence in older versus younger patients \[[@CR20], [@CR22], [@CR23], [@CR26], [@CR29]\], two in different older age groups \[[@CR19], [@CR32]\], and two studies described adherence in a single older age group \[[@CR21], [@CR34]\]. As the age limits of the groups varied and the ERP components assessed were too heterogeneous or limited in number, it was not possible to draw firm conclusions about adherence in relation to age. It was not possible either to draw conclusions about the factors that affect adherence among different age groups, such as location \[[@CR19], [@CR21], [@CR26]\] and invasiveness \[[@CR21]\] of the surgery, placement of a stoma \[[@CR21], [@CR26]\], and cancer diagnosis \[[@CR19], [@CR26]\]. Only a higher ASA class seems consistently associated with lower adherence \[[@CR20], [@CR26]\]. Possibly, ability to adhere to the programme in older patients may also be influenced by age-related factors: co-morbidity, frailty, functional impairments, cognitive impairments, ageism, or lack of personnel or materials (e.g. physiotherapists or walking aids) to take care of the more challenging older patients. Nevertheless, none of the presumed age-related factors above were studied.

A secondary objective of this review was to summarise outcomes of ERPs in older patients, without comparison to younger patients or conventional care: the two earlier reviews studied the safety and feasibility of ERPs (by analysing cohort studies comparing different age groups), and their efficacy (by analysing the only two existing RCTs of ERP versus conventional care in older patients \[[@CR24], [@CR28]\]). They concluded that ERPs are safe and feasible, with a comparable post-operative morbidity in the younger and older patient population in the majority of the studies, and that ERPs had significantly better outcomes than conventional care \[[@CR11], [@CR12]\]. In this novel review we included 8 new studies (we excluded emergency surgery, which explains why two studies from the previous reviews were not included). The outcomes in the new studies are comparable to those in the older studies. Unfortunately, differences in age ranges of recruited patients, differences in in- and exclusion criteria of the studies, differences in ERP pathways, and differences in definitions of outcomes or poorly defined ERP components and outcomes, and incomplete reporting of adherence preclude further causative analysis. Since the details of individual complications were very heterogeneously reported in studies, we decided to report overall complication rates. Only one study reported the incidence of postoperative delirium \[[@CR24]\].

Some methodological aspects need to be taken into account while interpreting the review results. First, only six studies included older patients or subgroups of older patients prospectively \[[@CR23], [@CR24], [@CR27], [@CR28], [@CR31], [@CR34]\]. The other studies were secondary analyses, database analyses or retrospective studies. Second, often only subgroups of patients from the original studies were included. For this reason, it was not possible to give more details about the included older population in terms of ratios for colon versus rectal surgery, laparoscopic versus open surgery, cancer versus benign disease, or ASA class. Third, the many differences among studies precluded meta-analysis of the results. Better quality research and standardised reporting is needed to draw conclusions on the optimal composition and the outcomes of the programme in older patients. Fourth, the included studies only report the chronological and not the biological age of their patients in terms of co-morbidity, frailty, mental capacity and functional dependency. The older patients in this review may be apt to selection bias, as mainly physically and mentally fit patients tend to be recruited in studies, and there might also be a referral bias \[[@CR46]\]. A strength of this review is the comprehensive search string with selection of papers in five different languages, without limitations on study design, and without searching for 'older patients'. This ensures a comprehensive overview of publications from the last 17 years describing the components, the adherence and the outcomes in (subgroups of) patients aged over 65 undergoing elective colorectal surgery.

The data provided by this review will be of added value to guide clinical decision-making and patient counselling. In addition, clinicians and researchers can use this overview as a reference to evaluate their own data. For future studies, there is a need to standardise and further fine-tune definitions of ERP intervention components and outcomes, and to provide guidance for standardised reporting \[[@CR42], [@CR47]\]. This will facilitate comparison among studies and allow meta-analysis. Adherence for all of the ERP components should be reported in a uniform way, and should reflect which ERP components patients actually receive, as well as which interventions they are able to carry out or tolerate. Large studies should describe patient characteristics, adherence and outcomes for their older patient groups in detail, to enable secondary analysis of the older patient population. Future studies and (inter)national audit initiatives will have to be specifically designed to study older patients in relation to their frailty profile, preferably incorporating a comprehensive geriatric assessment for the evaluation of the older individual's functional, cognitive and psychosocial status, comorbidities and polypharmacy \[[@CR10], [@CR48], [@CR49]\]. Based on these findings, it will be possible to thoroughly describe the older population studied. This will allow to determine whether frail older patients can follow a standard ERP or whether it should be tailored to this specific population, and to interpret outcomes in relation to older patients' profiles.

Conclusions {#Sec16}
===========

The ERP components applied in older patient populations were similar to those described in the ERP consensus guidelines, and the number of intervention components in the ERPs increased over time. Nevertheless, outcomes in earlier and later studies remained comparable. Although important to interpret outcomes, adherence rates were rarely reported. The pre- and intra-operative adherence (more dependent on the providers) was higher than the post-operative adherence (more influenced by patient-related factors). Future studies should explore adherence and age-related factors that could influence adherence, such as frailty profile.
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ASA

:   American society of anaesthesiologists physical status class

ERAS

:   Enhanced recovery after surgery

ERP

:   Enhanced recovery programme

GC

:   Global compliance

LOS

:   Length of stay

MINORS

:   Methodological index for non-randomised studies

PCIA

:   Patient controlled intravenous analgesia

POD

:   Post-operative day

PONV

:   Post-operative nausea and vomiting

RCT

:   Randomised controlled trial

TRD

:   Time to readiness for discharge

*An update of the 2012 ERAS® Society guideline is expected by the end of 2018.*
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